Cohort 4

DRUG3 trials

Sponsors

Brown University, Cougar Biotechnology, Inc., XOMA (US) LLC

Conditions

Congenital HyperinsulinismMetastatic Pancreatic CancerProstate CancerProstate Neoplasms

Phase 1

A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema

CompletedNCT00439179

Brown UniversityMetastatic Pancreatic Cancer

Start: 2006-07-31End: 2007-12-31Updated: 2020-02-17

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

CompletedNCT01400555

Cougar Biotechnology, Inc.Prostate Cancer, Prostate Neoplasms

Start: 2011-09-01End: 2017-02-28Updated: 2018-03-21

Phase 2

A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism

CompletedNCT02604485

XOMA (US) LLCCongenital Hyperinsulinism

Start: 2015-10-31End: 2017-01-31Updated: 2017-02-06

Related Papers

Phase 1b study of abiraterone acetate (AA) and docetaxel (D) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology2014-05-202 citations

Evaluating the safety of abiraterone acetate (AA) and docetaxel (D) administered in combination in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology2014-02-011 citations